KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Charles River Laboratories International (CRL) Shares Outstanding (2016 - 2025)

Charles River Laboratories International (CRL) has 11 years of Shares Outstanding data on record, last reported at $111000.0 in Q1 2022.

  • For Q1 2022, Shares Outstanding fell 99.78% year-over-year to $111000.0; the TTM value through Mar 2022 reached $111000.0, down 99.78%, while the annual FY2021 figure was $50.5 million, 1.43% up from the prior year.
  • Shares Outstanding reached $111000.0 in Q1 2022 per CRL's latest filing, down from $50.5 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $50.5 million in Q2 2021 and bottomed at $1000.0 in Q4 2018.
  • Average Shares Outstanding over 5 years is $30.6 million, with a median of $40.2 million recorded in 2018.
  • Peak YoY movement for Shares Outstanding: tumbled 100.0% in 2018, then soared 35989.86% in 2020.
  • A 5-year view of Shares Outstanding shows it stood at $1000.0 in 2018, then skyrocketed by 13800.0% to $139000.0 in 2019, then soared by 35703.6% to $49.8 million in 2020, then grew by 1.43% to $50.5 million in 2021, then crashed by 99.78% to $111000.0 in 2022.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding were $111000.0 in Q1 2022, $50.5 million in Q4 2021, and $147000.0 in Q3 2021.